Drug:
Reaction: DEATH
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26943913 |
IN |
66 | 2 |
Death, Metastases to central nervous system, Blood pressure systolic increased, Blood glucose abnormal, Lipids abnormal, Oxygen saturation decreased, Ageusia, Mean arterial pressure increased, Respiratory rate increased, Thyroid function test abnormal, |
||||
LORLATINIB, LORLATINIB, LORLATINIB, LORLATINIB, LORLATINIB, LORLATINIB, |
||||
| 102 | 26943924 |
GB |
87 | 1 |
Death, |
||||
TAFAMIDIS MEGLUMINE, |
||||
| 103 | 26943926 |
AR |
81 | 1 |
Death, |
||||
TAFAMIDIS, |
||||
| 104 | 26944021 |
CA |
70 | 2 |
Death, Head and neck cancer, |
||||
UPADACITINIB, |
||||
| 105 | 26944023 |
CA |
74 | 2 |
Death, Pneumonia, Cardiac failure, Malaise, Peripheral swelling, Erythema, Arthralgia, Visual impairment, Gastroenteritis, |
||||
BENRALIZUMAB, BENRALIZUMAB, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, |
||||
| 106 | 26944024 |
US |
75 | |
Death, |
||||
RESMETIROM, |
||||
| 107 | 26944064 |
US |
53 | 2 |
Death, Hospitalisation, |
||||
BOSENTAN, |
||||
| 108 | 26944110 |
CN |
||
Death, |
||||
RITUXIMAB, |
||||
| 109 | 26944156 |
61 | 2 | |
Death, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, GABAPENTIN, ERGOCALCIFEROL, |
||||
| 110 | 26944157 |
2 | ||
Death, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 111 | 26944169 |
CO |
65 | 1 |
Death, Pyrexia, Platelet count decreased, Haemoglobin decreased, |
||||
VENETOCLAX, |
||||
| 112 | 26944249 |
ZA |
40 | |
Death, |
||||
| 113 | 26944317 |
36 | 2 | |
Death, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 114 | 26944342 |
2 | ||
Death, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 115 | 26944354 |
87 | 2 | |
Death, |
||||
ADALIMUMAB, |
||||
| 116 | 26944358 |
85 | 2 | |
Death, |
||||
INAVOLISIB, |
||||
| 117 | 26944359 |
78 | 2 | |
Death, |
||||
DUPILUMAB, IRBESARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SERTRALINE, LATANOPROST, |
||||
| 118 | 26944364 |
78 | 1 | |
Death, |
||||
COLLAGENASE SANTYL, |
||||
| 119 | 26944404 |
EU |
96 | 1 |
Death, |
||||
RISANKIZUMAB-RZAA, |
||||
| 120 | 26944432 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 121 | 26944476 |
60 | 2 | |
Death, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 122 | 26944512 |
SG |
69 | 1 |
Death, Surgery, Drug ineffective, |
||||
BEVACIZUMAB, |
||||
| 123 | 26944515 |
US |
35 | 1 |
Death, Weight decreased, Decreased appetite, Coordination abnormal, Fall, Off label use, |
||||
CANNABIDIOL, CANNABIDIOL, |
||||
| 124 | 26944657 |
IL |
1 | |
Death, |
||||
DEFIBROTIDE SODIUM, |
||||
| 125 | 26944659 |
CA |
63 | 2 |
Death, Hospitalisation, |
||||
ELAFIBRANOR, URSODIOL, URSOSIOL, CALCIUM, ESOMEPRAZOLE MAGNESIUM, TRIMETHOPRIM, ROSUVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, |
||||
| 126 | 26944766 |
CN |
2 | |
Death, |
||||
LORLATINIB, |
||||
| 127 | 26944804 |
CO |
49 | 1 |
Death, |
||||
PANITUMUMAB, |
||||
| 128 | 26944836 |
GB |
||
Death, |
||||
SELINEXOR, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 129 | 26944856 |
EU |
84 | 2 |
Death, |
||||
| 130 | 26944876 |
US |
1 | |
Death, |
||||
| 131 | 26944925 |
JP |
65 | 1 |
Death, |
||||
CABOZANTINIB, NIVOLUMAB, IPILIMUMAB, |
||||
| 132 | 26944983 |
46 | 2 | |
Death, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 133 | 26945456 |
GB |
75 | 1 |
Death, |
||||
| 134 | 26945597 |
US |
1 | |
Death, |
||||
PEMBROLIZUMAB, |
||||
| 135 | 26945598 |
IN |
75 | 1 |
Death, |
||||
DURVALUMAB, |
||||
| 136 | 26945643 |
GB |
1 | |
Death, |
||||
CLOZAPINE, |
||||
| 137 | 26945702 |
US |
1 | |
Death, |
||||
NIVOLUMAB, IPILIMUMAB, |
||||
| 138 | 26945813 |
JP |
57 | 1 |
Death, |
||||
ELRANATAMAB-BCMM, |
||||
| 139 | 26945874 |
CA |
82 | 2 |
Death, |
||||
ONABOTULINUMTOXINA, |
||||
| 140 | 26945932 |
US |
89 | |
Death, |
||||
VUTRISIRAN, VUTRISIRAN, |
||||
| 141 | 26945935 |
US |
83 | |
Death, Product dose omission issue, |
||||
VUTRISIRAN, |
||||
| 142 | 26946016 |
US |
59 | 1 |
Death, Hospice care, Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 143 | 26946148 |
US |
70 | |
Death, |
||||
CENOBAMATE, CENOBAMATE, |
||||
| 144 | 26946425 |
CO |
70 | 1 |
Death, |
||||
ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, |
||||
| 145 | 26946747 |
US |
2 | |
Death, |
||||
RAVULIZUMAB, |
||||
| 146 | 26946879 |
CA |
2 | |
Death, |
||||
BENRALIZUMAB, BENRALIZUMAB, LORAZEPAM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 147 | 26946991 |
US |
65 | |
Death, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 148 | 26947047 |
AU |
||
Death, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 149 | 26947076 |
AU |
||
Death, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 150 | 26947110 |
2 | ||
Death, |
||||
TENAPANOR HYDROCHLORIDE, |
||||
| 151 | 26947121 |
US |
73 | 1 |
Death, Drug ineffective, Urinary tract infection, |
||||
TIOPRONIN, CARBIDOPA AND LEVODOPA, PRAMIPEXOLE, |
||||
| 152 | 26947285 |
GB |
2 | |
Death, |
||||
EVOLOCUMAB, |
||||
| 153 | 26947286 |
JP |
77 | 1 |
Death, |
||||
ECULIZUMAB, |
||||
| 154 | 26947605 |
JP |
9 | 1 |
Death, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 155 | 26947695 |
IN |
73 | 2 |
Death, |
||||
OSIMERTINIB, |
||||
| 156 | 26947756 |
IN |
64 | 1 |
Death, |
||||
OSIMERTINIB, |
||||
| 157 | 26947804 |
CA |
63 | 2 |
Death, |
||||
SOTORASIB, SOTORASIB, |
||||
| 158 | 26947817 |
US |
83 | 2 |
Death, |
||||
ACALABRUTINIB, FLUTICASONE PROPIONATE, |
||||
| 159 | 26947900 |
US |
1 | |
Death, |
||||
PANCRELIPASE, |
||||
| 160 | 26948026 |
US |
76 | 2 |
Death, |
||||
ADALIMUMAB, |
||||
| 161 | 26948027 |
CA |
78 | 1 |
Death, |
||||
| 162 | 26948070 |
PR |
52 | 2 |
Death, |
||||
ADALIMUMAB, |
||||
| 163 | 26948235 |
US |
45 | 2 |
Death, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 164 | 26950967 |
1 | ||
Death, |
||||
AMBRISENTAN, |
||||
| 165 | 26951150 |
1 | ||
Death, |
||||
COLLAGENASE SANTYL, |
||||
| 166 | 26951154 |
52 | 2 | |
Death, |
||||
ADALIMUMAB-AATY, |
||||
| 167 | 26951169 |
1 | ||
Death, |
||||
TAFAMIDIS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 168 | 26951291 |
82 | 1 | |
Death, |
||||
DUPILUMAB, PREDNISONE, MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 169 | 26951379 |
|||
Death, |
||||
LORLATINIB, |
||||
| 170 | 26951380 |
2 | ||
Death, |
||||
TADALAFIL, AMBRISENTAN, |
||||
| 171 | 26951655 |
51 | 1 | |
Death, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, |
||||
| 172 | 26951662 |
76 | 1 | |
Death, |
||||
ISTRADEFYLLINE, TAMSULOSIN HYDROCHLORIDE, |
||||
| 173 | 26952104 |
79 | 1 | |
Death, |
||||
ALECTINIB HYDROCHLORIDE, |
||||
| 174 | 26952123 |
35 | 2 | |
Death, |
||||
DROXIDOPA, |
||||
| 175 | 26952191 |
85 | 2 | |
Death, |
||||
GUSELKUMAB, |
||||
| 176 | 26952193 |
76 | 2 | |
Death, |
||||
DIROXIMEL FUMARATE, |
||||
| 177 | 26952198 |
82 | 2 | |
Death, |
||||
ABALOPARATIDE, |
||||
| 178 | 26952203 |
66 | 2 | |
Death, |
||||
DENOSUMAB, |
||||
| 179 | 26952204 |
90 | 1 | |
Death, |
||||
ELTROMBOPAG OLAMINE, |
||||
| 180 | 26934116 |
US |
78 | 2 |
Death, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 181 | 26934260 |
CA |
88 | 1 |
Death, |
||||
| 182 | 26934318 |
US |
2 | |
Death, |
||||
DENOSUMAB, |
||||
| 183 | 26934681 |
US |
62 | 1 |
Death, Off label use, |
||||
AVACOPAN, AVACOPAN, |
||||
| 184 | 26934781 |
US |
39 | |
Death, |
||||
EDARAVONE, EDARAVONE, |
||||
| 185 | 26934797 |
EU |
2 | |
Death, |
||||
PANITUMUMAB, |
||||
| 186 | 26934807 |
HK |
2 | |
Death, |
||||
| 187 | 26934894 |
EU |
1 | |
Death, |
||||
PANITUMUMAB, |
||||
| 188 | 26934940 |
GB |
1 | |
Death, Neoplasm malignant, Dyspnoea, Product dose omission issue, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 189 | 26934969 |
US |
69 | 1 |
Death, Incorrect dose administered, |
||||
RELUGOLIX, DAROLUTAMIDE, |
||||
| 190 | 26934973 |
US |
71 | 1 |
Death, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 191 | 26934979 |
US |
88 | 2 |
Death, |
||||
VIBEGRON, |
||||
| 192 | 26935006 |
IN |
2 | |
Death, |
||||
OSIMERTINIB, |
||||
| 193 | 26935008 |
AU |
75 | 1 |
Death, |
||||
| 194 | 26935024 |
CA |
1 | |
Death, |
||||
FARICIMAB, |
||||
| 195 | 26935059 |
NP |
1 | |
Death, |
||||
RIBOCICLIB, |
||||
| 196 | 26935062 |
US |
1 | |
Death, |
||||
OSIMERTINIB, |
||||
| 197 | 26935070 |
US |
85 | 2 |
Death, |
||||
OSIMERTINIB, |
||||
| 198 | 26935121 |
US |
||
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 199 | 26935122 |
MX |
2 | |
Death, |
||||
PANITUMUMAB, |
||||
| 200 | 26935132 |
IN |
1 | |
Death, |
||||
DURVALUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30